Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2009

Mar 3, 2009

33510_dirs_2009-03-03_cac84054-e9a6-490f-8261-d58f86779469.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2009-02-26

Reporting Person: Babcock Dwight William (Director, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-26 Common stock P 47054 $0.2 Acquired 127561 Direct
2009-02-27 Common stock P 600 $0.2 Acquired 128161 Direct